Search Results - "Spellmann, I."

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine by MÜLLER, N, SCHWARZ, M. J, MÖLLER, H.-J, AROLT, V, RIEDEL, M, DEHNING, S, DOUHE, A, CEROVECKI, A, GOLDSTEIN-MÜLLER, B, SPELLMANN, I, HETZEL, G, MAINO, K, KLEINDIENST, N

“…Signs of an inflammatory process, in particular increased pro-inflammatory cytokines and increased levels of prostaglandine E(2) (PGE(2)), have repeatedly been…”
Get full text

Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression — No influence of celecoxib treatment by Musil, R, Schwarz, M.J, Riedel, M, Dehning, S, Cerovecki, A, Spellmann, I, Arolt, V, Müller, N

“…Abstract Objectives The involvement of an immune process in the pathophysiology of major depression disorder (MDD) was substantiated by studies demonstrating…”
Get full text

EPA-1415 – Pharmacogenetics of antipsychotic-induced weight gain in schizophrenic patients by Musil, R, Spellmann, I, Riedel, M, Rospleszcz, S, Borck, A, Falkai, P, Zill, P

“…Background Antipsychotic-induced weight gain (AIWG) is a major drawback in the treatment of schizophrenic patients with second-generation antipsychotics…”
Get full text

The RSM-scale: a pilot study on a new specific scale for self- and observer-rated quality of life in patients with schizophrenia by Riedel, M., Spellmann, I., Schennach-Wolff, R., Obermeier, M., Musil, R.

“…Purpose To develop and evaluate a self-and observerrating scale on quality of life in patients suffering from schizophrenia with regard to the efficacy of…”
Get full text

Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone by Riedel, M., Schennach-Wolff, R., Musil, R., Dehning, S., Cerovecki, A., Opgen-Rhein, M., Matz, J., Seemüller, F., Obermeier, M., Engel, R. R., Müller, N., Möller, H.-J., Spellmann, I.

“…Background To examine influencing variables of neurocognition in patients with schizophrenia and to predict cognition during antipsychotic treatment. Methods…”
Get full text

Effect of aripiprazole on cognition in the treatment of patients with schizophrenia by Riedel, M, Spellmann, I, Schennach-Wolff, R, Musil, R, Dehning, S, Cerovecki, A, Opgen-Rhein, M, Matz, J, Seemüller, F, Obermeier, M, Severus, E, Engel, R R, Müller, N, Möller, H-J

“…The aim of this study was to assess the cognitive effects of aripiprazole in inpatients with schizophrenia. This was an investigator-initiated, open label…”
Get more information

The validity of self-rated psychotic symptoms in depressed inpatients by Seemüller, F, Riedel, M, Obermeier, M, Schennach-Wolff, R, Spellmann, I, Meyer, S, Bauer, M, Adli, M, Kronmüller, K, Ising, M, Brieger, P, Laux, G, Bender, W, Heuser, I, Zeiler, J, Gaebel, W, Möller, H.-J

“…Abstract Background Self-ratings of psychotic experiences might be biased by depressive symptoms. Method Data from a large naturalistic multicentre trial on…”
Get full text

IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia by Schwarz, Markus J, Krönig, Holger, Riedel, Michael, Dehning, Sandra, Douhet, Anette, Spellmann, Ilja, Ackenheil, Manfred, Möller, Hans-Jürgen, Müller, Norbert

“…An immune process, characterized by a relative predominance of the T helper-2 (Th2) system and possibly induced by a viral infection,may be involved in the…”
Get full text

Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation by Meisenzahl, E M, Scheuerecker, J, Zipse, M, Ufer, S, Wiesmann, M, Frodl, T, Koutsouleris, N, Zetzsche, T, Schmitt, G, Riedel, M, Spellmann, I, Dehning, S, Linn, J, Brückmann, H, Möller, H J

“…Working memory as a part of higher-order executive functions is defined by the parallel storage and processing of information. Recent functional fMRI studies…”
Get full text

Risperidone plasma levels, clinical response and side–effects by Riedel, M., Schwarz, M. J., Strassnig, M., Spellmann, I., Müller–Arends, A., Weber, K., Zach, J., Müller, N., Möller, H. J.

Get full text

Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms by Riedel, Michael, Müller, Norbert, Strassnig, Martin, Spellmann, Ilja, Engel, Rolf R, Musil, Richard, Dehning, Sandra, Douhet, Anette, Schwarz, Markus J, Möller, Hans-Jürgen

“…Atypical antipsychotics are generally thought to be more effective than conventional agents in treating the negative symptoms of schizophrenia; however, there…”
Get full text

S28-04 - Pharmacogenetics of extrapyramidal motor side effects in the treatment of schizophrenia by Musil, R, Rujescu, D, Spellmann, I, Mayr, A, Zill, P, Giegling, I, Bondy, B, Müller, N, Möller, H.-J, Riedel, M

“…Introduction Since the introduction of second generation antipsychotics (SGA) extrapyramidal-motor symptoms (EPS) have become a lesser problem in the treatment…”
Get full text

S28-03 - Pharmacogenetics of therapy response in schizophrenia by Spellmann, I, Rujescu, D, Musil, R, Mayr, A, Giegling, I, Genius, J, Zill, P, Dehning, S, Hartmann, A.M, Bondy, B, Müller, N, Möller, H.-J, Riedel, M

“…Pharmacogenetics in schizophrenia comprises pharmacokinetical and pharmacodynamical aspects as well as an approach to identify candidate genes associated with…”
Get full text

P.1.a.017 Synaptosomal-associated protein of 25kDa (SNAP-25) polymorphisms and cognitive dysfunctions in schizophrenic patients during an atypical antipsychotic treatment by Spellmann, I, Müller, N, Bondy, B, Musil, R, Zill, P, Möller, H.J, Riedel, M

Get full text

P.3.d.016 Homer 1 and metabotropic glutamate- receptor 5 polymorphisms are associated with response to treatment in schizophrenia by Musil, R, Spellmann, I, Zill, P, Bondy, B, Douhet, A, Dehning, S, Severus, E, Müller, N, Möller, H.J, Riedel, M

Get full text

Risperidone plasma levels, clinical response and side-effects by Riedel, Michael, Schwarz, M J, Strassnig, M, Spellmann, I, Müller-Arends, A, Weber, K, Zach, J, Müller, N, Möller, H J

“…Assessment of the relation between oral risperidone dose, serum drug levels and clinical response may provide important information for rational treatment…”
Get full text

Decreased T cellular immune response in schizophrenic patients by Riedel, Michael, Spellmann, Ilja, Schwarz, Markus J, Strassnig, Martin, Sikorski, Christopher, Möller, Hans-Jürgen, Müller, Norbert

“…Abstract The involvement of an alteration of the immune system in the pathogenesis of schizophrenia is discussed since many years. In particular, in vitro…”
Get full text

A genetic variant of HTR2C may play a role in the manifestation of Tourette syndrome by Dehning, Sandra, Müller, Norbert, Matz, Judith, Bender, Andreas, Kerle, Irina, Benninghoff, Jens, Musil, Richard, Spellmann, Ilja, Bondy, Brigitta, Möller, Hans-Juergen, Riedel, Michael, Zill, Peter

“…Gilles de la Tourette syndrome (GTS) (MIM 137580) is a complex neuropsychiatric disorder probably originating from a disturbed interplay of several…”
Get full text

The association between peripheral and CSF kynurenine metabolites in patients with affective disorders and Schizophrenia by Myint, A M, Schwarz, M J, Spellmann, I, Zach, J, Müller, N, Reidel, M

Get full text

28. Changes in prolactin levels as predictor of response to treatment with aripiprazole by Musil, Richard, Riedel, Michael, Spellmann, Ilja, Opgen-Rhein, Markus, Schwarz, Markus J

Get full text